-
Experts Compare JIA Outcomes Across the World
Juvenile idiopathic arthritis outcomes vary greatly across the world, possibly due to genetic factors, referral biases, and differential access to treatment. Daniel Horton, MD, MS, discussed disease variations across North America.
More news from #ACR24
-
Authors Give Overview of the New ACR Lupus Nephritis Guideline
Lead author Lisa Sammaritano, MD, discussed the development of the 2024 ACR guideline for the screening, treatment, and management of lupus nephritis and key recommendations, including a kidney biopsy for patients with suspected disease.
-
State of the Art Lecture Explores Precision Medicine in Systemic Sclerosis
In a discussion on molecular phenotypes and functional response biomarkers in systemic sclerosis, Francesco Del Galdo, MD, PhD, discussed data-driven approaches to managing the clinical manifestations of the disease.
ACR Convergence Newsmakers
-
Year in Preview Examines Outlook for Biomarkers, CAR-T Therapy, Anti-Obesity Drugs, and Other Emerging Therapies in Rheumatic Disease
Grace Wright, MD, PhD, FACR, and Christopher Ritchlin, MD, MPH, discussed key presentations at ACR Convergence 2024 that highlighted new developments in rheumatology that are most likely to impact patient care and outcomes.
-
Educators Teach Critical Lessons for Turning Academic Projects into Scholarly Successes
Many educators struggle to write effective learning objectives. Rebecca Sadun, MD, PhD, offered tips on how medical educators can create actionable, measurable, observable, and specific learning objectives to help learners succeed.
-
Experts Explain How to Differentiate Serious Infectious Disease from Rheumatic Conditions in Children
Some infectious diseases can mimic rheumatic disorders. In a session on identifying these mimics, Joyce Hui-Yuen, MD, MS, highlighted leprosy, or Hansen’s disease, in children.
Poster Spotlight
